Get started
Celcuity Inc.Celcuity Inc.Celcuity Inc.

Celcuity Inc.

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonalsOptionsETFsBonds
Full chart
Full chart

Compare with Celcuity Inc.



Key facts today


Celcuity (CELC) got FDA approval for REVTORPYK in second-line metastatic breast cancer, plans commercial launch this quarter, and has an sNDA for PIK3CA‑mutant patients under review. 1
Analyze the impactAnalyze the impact

Key stats


Market capitalization
‪4.68 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−4.30 USD
Net income (FY)
‪−177.04 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪40.09 M‬
Beta (1Y)
2.15

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Employees


Employees (FY)
155
Change (1Y)
+68+78.16%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.14 M‬ USD

Company info


Sector
Health Technology
Industry
Medical Specialties
CEO
Brian F. Sullivan
Website
celcuity.com
Headquarters
Minneapolis
Founded
2012
IPO date
Sep 20, 2017
ISIN
US15102K1007
CUSIP
15102K100
FIGI
BBG00HKBW045
Identifiers
ISIN US15102K1007
CFI code
ESVUFR
Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Highest yielding bonds


— YTM
Maturity dateAug 1, 2032
Coupon0.25% (Fixed)
— YTM
Maturity dateAug 1, 2031
Coupon2.75% (Fixed)

See all CELC bonds 

ETFs holding the stock


XBI
State Street SPDR S&P Biotech ETF
Weight1.01%
Market value‪114.70 M‬
IWM
iShares Russell 2000 Index Fund
Weight0.12%
Market value‪94.32 M‬
VXF
Vanguard Extended Market ETF
Weight0.04%
Market value‪37.83 M‬
IWO
iShares Russell 2000 Growth Fund
Weight0.23%
Market value‪34.20 M‬
VTWO
Vanguard Russell 2000 ETF
Weight0.10%
Market value‪18.65 M‬
SCHA
Schwab U.S. Small-Cap ETF
Weight0.08%
Market value‪17.29 M‬
ZPRR
State Street SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF Accum Ptg USD
Weight0.11%
Market value‪6.53 M‬
R2EH
State Street SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF Accum Shs - Hedged EUR
Weight0.11%
Market value‪6.53 M‬
FESM
Fidelity Enhanced Small Cap Core ETF
Weight0.09%
Market value‪6.09 M‬
CANC
Tema Oncology ETF
Weight1.91%
Market value‪4.12 M‬
VHT
Vanguard Health Care ETF
Weight0.02%
Market value‪4.11 M‬

Explore more ETFs 

Frequently asked questions


The current price of CELC is 93.02 USD — it has increased by 0.34% in the past 24 hours. Watch Celcuity Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Celcuity Inc. stocks are traded under the ticker CELC.
CELC stock has risen by 7.90% compared to the previous week, the month change is a 1.09% rise, over the last year Celcuity Inc. has showed a 66.76% increase.
We've gathered analysts' opinions on Celcuity Inc. future price: according to them, CELC price has a max estimate of 177.00 USD and a min estimate of 140.00 USD. Watch CELC chart and read a more detailed Celcuity Inc. stock forecast: see what analysts think of Celcuity Inc. and suggest that you do with its stocks.
CELC reached its all-time high on May 4, 2026 with the price of 151.02 USD, and its all-time low was 4.03 USD and was reached on Apr 16, 2020. View more price dynamics on CELC chart.
See other stocks reaching their highest and lowest prices.
CELC stock is 5.20% volatile and has beta coefficient of 2.15. Track Celcuity Inc. stock price on the chart and check out the list of the most volatile stocks — is Celcuity Inc. there?
Today Celcuity Inc. has the market capitalization of ‪4.68 B‬, it has decreased by −3.26% over the last week.
Yes, you can track Celcuity Inc. financials in yearly and quarterly reports right on TradingView.
Celcuity Inc. is going to release the next earnings report on Nov 18, 2026. Keep track of upcoming events with our Earnings Calendar.
CELC earnings for the last quarter are −1.44 USD per share, whereas the estimation was −1.16 USD resulting in a −23.65% surprise. The estimated earnings for the next quarter are −1.41 USD per share. See more details about Celcuity Inc. earnings.
Celcuity Inc. revenue for the last quarter amounts to 0.00 USD, despite the estimated figure of 0.00 USD. In the next quarter, revenue is expected to reach ‪4.26 M‬ USD.
CELC net income for the last quarter is ‪−78.86 M‬ USD, while the quarter before that showed ‪−52.84 M‬ USD of net income which accounts for 0.00% change. Track more Celcuity Inc. financial stats to get the full picture.
No, CELC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 8, 2026, the company has 155 employees. See our rating of the largest employees — is Celcuity Inc. on this list?
Like other stocks, CELC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Celcuity Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Celcuity Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Celcuity Inc. stock shows the buy signal. See more of Celcuity Inc. technicals for a more comprehensive analysis.